UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of clinical oncology, ISSN 0732-183X, 07/2016, Volume 34, Issue 20, pp. 2380 - 2388
Life Sciences & Biomedicine | Oncology | Science & Technology | Dexamethasone - administration & dosage | Humans | Child, Preschool | Dexamethasone - adverse effects | Infant | Male | Young Adult | Methotrexate - adverse effects | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adult | Female | Methotrexate - administration & dosage | Child | Index Medicus | ORIGINAL REPORTS | Pedi2
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2015, Volume 33, Issue 27, pp. 2938 - 2948
Life Sciences & Biomedicine | Oncology | Science & Technology | Predictive Value of Tests | Genetic Testing | History, 21st Century | Humans | Child, Preschool | Infant | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Time Factors | Child | Infant, Newborn | Precision Medicine | Pediatrics - trends | Genetic Predisposition to Disease | History, 20th Century | Survivors | Cooperative Behavior | Treatment Outcome | International Cooperation | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Interdisciplinary Communication | Phenotype | Medical Oncology - trends | Adolescent | Age of Onset | Diffusion of Innovation | Biomarkers, Tumor - genetics | Index Medicus | Pedi2 | Review
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2011, Volume 29, Issue 5, pp. 551 - 565
Life Sciences & Biomedicine | Oncology | Science & Technology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Recurrence | Genetic Predisposition to Disease | Genome-Wide Association Study | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Humans | Transcription, Genetic | Leukemia, Myeloid, Acute - etiology | Mutation | Child | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - genetics | Index Medicus | Pedi2 | Review | Pedi3
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2015, Volume 33, Issue 27, pp. 3065 - 3073
Life Sciences & Biomedicine | Oncology | Science & Technology | Pediatrics - trends | Health Status Disparities | Humans | Survivors | Cooperative Behavior | Neoplasms - mortality | Treatment Outcome | International Cooperation | Neoplasms - diagnosis | Remission Induction | Young Adult | Interdisciplinary Communication | Neoplasms - therapy | Neoplasms - ethnology | Time Factors | Global Health - trends | Medical Oncology - trends | Adolescent | Age of Onset | Diffusion of Innovation | Healthcare Disparities - trends | Child | Index Medicus | Pedi18 | Pedi17 | Pedi19 | Pedi9 | Pedi6 | Pedi7 | Review | Pedi4 | Pedi5 | Pedi2 | Pedi3 | Pedi10 | Pedi20 | Pedi12 | Pedi23 | Pedi11 | Pedi22 | Pedi14 | Pedi25 | Pedi13 | Pedi24 | Pedi16 | Pedi15
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 17, pp. 2136 - 2145
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Young Adult | United States | Humans | Adolescent | Adult | Female | Male | Treatment Outcome | Neoplasms - psychology | Quality of Life - psychology | Neoplasms - physiopathology | Index Medicus | Pedi9 | Pedi6 | Pedi12 | Pedi11 | Psc12 | ORIGINAL REPORTS | Pedi2 | Pedi16 | Psc13
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2015, Volume 33, Issue 11, pp. 1235 - 1242
Life Sciences & Biomedicine | Oncology | Science & Technology | Prospective Studies | Age Factors | Humans | Asian Continental Ancestry Group - genetics | Pyrophosphatases - genetics | Antimetabolites, Antineoplastic - administration & dosage | Genetic Variation | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Drug Dosage Calculations | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Hispanic Americans - genetics | Pharmacogenetics | Gene Frequency | Risk Factors | Mercaptopurine - administration & dosage | Mercaptopurine - adverse effects | Linear Models | Treatment Outcome | Heredity | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Pyrophosphatases - metabolism | Homozygote | Phenotype | Precursor Cell Lymphoblastic Leukemia-Lymphoma - ethnology | Antimetabolites, Antineoplastic - adverse effects | Heterozygote | Index Medicus | Hema5 | ORIGINAL REPORTS | To2 | Hema9 | Pedi2
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 08/2014, Volume 32, Issue 23, pp. 2391 - 2397
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2014, Volume 32, Issue 27, pp. 3012 - 3020
Life Sciences & Biomedicine | Oncology | Science & Technology | Risk Assessment | Humans | Risk Factors | Kaplan-Meier Estimate | Child, Preschool | Infant | Male | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Fusion Proteins, bcr-abl - drug effects | Neoplasm, Residual - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Fusion Proteins, bcr-abl - genetics | Adolescent | Neoplasm, Residual - drug therapy | Female | Antineoplastic Agents - pharmacology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Child | Molecular Targeted Therapy - methods | Salvage Therapy - methods | Index Medicus | ORIGINAL REPORTS | Hema9 | Pedi2
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 06/2012, Volume 30, Issue 17, pp. 2094 - 2101
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Recurrence | Administration, Oral | United States | Humans | Hispanic Americans | Mercaptopurine - administration & dosage | Child, Preschool | Infant | Male | Risk | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Medication Adherence | Time Factors | Precursor Cell Lymphoblastic Leukemia-Lymphoma - ethnology | Adolescent | Adult | Female | Surveys and Questionnaires | Child | Index Medicus | Original Reports | Pedi19 | Pedi24 | Pedi2
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 31, pp. 5175 - 5181
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Piperazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Bone Marrow Transplantation | Adult | Female | Child | Philadelphia Chromosome | Pyrimidines - administration & dosage | Risk Factors | Kaplan-Meier Estimate | Imatinib Mesylate | Piperazines - adverse effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Adolescent | Pyrimidines - adverse effects | Benzamides | Index Medicus | Original Reports | Hema5 | Bios3 | Pedi2
Journal Article